Nov 10, 2021 / 06:00PM GMT
Gretel Janu - Crédit Suisse AG - Research Division - Research Analyst
Hello, everyone. So my name is Gretel Janu. I'm the Australian Healthcare Analyst. I am very pleased to have Mick Farrell, CEO of ResMed here with us today for a fireside chat. As we go through the fireside chat if you have any questions, please feel free to send them through to my email, that's [email protected] and I'll throw your questions into our conversation here today. So Nick, thank you so much for joining us today, and thanks for participating in our conference. It's definitely been a very exciting, interesting period for ResMed over the last 12 to 18 months with COVID recovery, supply chain challenges and now the Philips recall. So I guess to start off, do you want to mention how ResMed is responding at the moment to all of these different challenges. And how is ResMed's positioned to continue to grow strongly through the medium term and into longer term. Thank you.
Michael J. Farrell - ResMed Inc. - CEO & Director
Yes, Gretel, great opener.
Resmed Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers